AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Biosensor for Detecting Viscosity Changes

Summary
Researchers at Purdue University have developed and designed miniaturized platforms for analyzing biopharmaceutical degradation. This technology provides significant advantages to current macroscale systems and allows for rapid testing of pharmaceuticals outside of the quality control laboratory using small sample volumes. The method has been proven with several different biopharmaceutical formulations and can discriminate as little as 5 percent degradation of insulin in a solution. This technology is a new tool for biopharmaceutical analysis and could readily be implemented at key points of the pharmaceutical delivery chain.
Technology Benefits
Requires only a small sample to test Eliminates the need for lab testing Eliminates waste by discriminating degraded vs. intact product Eliminates risk of using inactive biopharmaceutical for patients
Technology Application
Insulin testing Biopharmaceutical efficacy tests
Detailed Technology Description
Steve WereleyPurdue Microfluidics GroupPurdue Mechanical Engineering
Countries
United States
Application No.
None
*Abstract

*Background
When pharmaceutical preparations are improperly stored, drug safety and efficacy need to be monitored to ensure that the pharmaceutic delivers its intended effect and to prevent potential illness from degraded product. Current screening platforms for the stability of protein-based biopharmaceuticals in high throughput and low volume are unavailable outside of production and quality control laboratories. Miniaturized platforms for analyzing biopharmaceutical degradation could provide significant advantages to current macroscale systems. These include the ability to assess the quality of a pharmaceutical either during development, at distribution points, at the clinic, or within patient homes.
*IP Issue Date
None
*IP Type
Provisional
*Stage of Development
Concept validated through theory, simulation, or models
*Web Links
Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipSteve WereleyPurdue Microfluidics GroupPurdue Mechanical Engineering
Country/Region
USA

For more information, please click Here
Mobile Device